Cision PR Newswire

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk...

WeRide Launches Robovan W5, Pioneering New Class of Autonomous Delivery Vehicle

GUANGZHOU, China, Feb. 6, 2025 /PRNewswire/ -- WeRide Inc. (NASDAQ: WRD), a global leader in autonomous driving technology, today launched the Robovan W5, featuring self-developed Level...

Henlius and Dr. Reddy’s Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

SHANGHAI, Feb. 6, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned...

The Maybourne Saint-Germain: Maybourne to bring palace-style hotel and ultra-luxury branded residences to a historic landmark in Paris

LONDON, Feb. 6, 2025 /PRNewswire/ -- Maybourne has today announced a 2027 opening for its newest development in the Parisian quarter of Saint-Germain-des-Prés, The...

Hexagon Purus upgrades to IFS Cloud to drive supply chain efficiency and optimize global growth

Leader in zero emissions mobility and infrastructure technology will deploy IFS.ai capabilities to meet global demand for market-leading hydrogen and battery electric technologies. LONDON, Feb....